e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cytomegalovirus: an unrecognised potential contributor to cystic fibrosis disease progression?
Michael D. Parkins, Kathleen J. Ramos, Christopher H. Goss, Ranjani Somayaji
Source:
Eur Respir J, 53 (4) 1801727; 10.1183/13993003.01727-2018
Journal Issue:
April
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Michael D. Parkins, Kathleen J. Ramos, Christopher H. Goss, Ranjani Somayaji. Cytomegalovirus: an unrecognised potential contributor to cystic fibrosis disease progression?. Eur Respir J, 53 (4) 1801727; 10.1183/13993003.01727-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Related content which might interest you:
Idiopathic pulmonary fibrosis: another step in understanding the burden of this disease
Source: Eur Respir J 2016; 48: 26-28
Year: 2016
Monitoring early lung disease in cystic fibrosis: where are we now?
Source: Breathe 2014; 10: 34-47
Year: 2014
Cystic fibrosis related pulmonary disease: more structure than function?
Source: Eur Respir J 2005; 26: Suppl. 49, 729s
Year: 2005
Idiopathic pulmonary fibrosis: a treatable disease?
Source: Eur Respir J 2003 Dec 01;22(6):872-873
Year: 2003
Elucidating progression of early cystic fibrosis lung disease
Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017
Year: 2017
Aspergillus
-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?
Source: Eur Respir Rev, 30 (162) 210103; 10.1183/16000617.0103-2021
Year: 2021
Factors affecting progression of lung disease among patients with cystic fibrosis
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
Evolution of the infectious disease in cystic fibrosis (CF)
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008
Cystic interstitial lung disease - a rare disease?
Source: International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease
Year: 2015
Endotrophin is related to disease progression in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020
How much genotype influences cystic fibrosis associated liver disease?
Source: Eur Respir J 2006; 28: Suppl. 50, 717s
Year: 2006
Risk factors for lung disease progression in children with cystic fibrosis
Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017
Year: 2018
Risk factors for lung disease progression in children with cystic fibrosis
Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018
Year: 2018
A model for active and healthy ageing with a rare genetic disease: cystic fibrosis
Source: Eur Respir J 2016; 47: 714-719
Year: 2016
Cystic fibrosis and bone disease: are we missing a genetic link?
Source: Eur Respir J 2005; 25: 9-11
Year: 2005
Early determinants of lung disease in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent
Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019
Year: 2020
Lung inflammation in cystic fibrosis: an overlooked therapeutic target?
Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age
Year: 2020
Risk factors for progression of cystic fibrosis lung disease from childhood to adulthood
Source: Virtual Congress 2020 – Respiratory diseases in children and adults
Year: 2020
Cystic fibrosis a contagious disease. Need for segregation
Source: Annual Congress 2005 - Paediatric year in review
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept